The Office of the Secretary of Defense Manufacturing Technology Program, or OSD ManTech, shared on LinkedIn Wednesday that it has unveiled two new biomanufacturing facilities during BioMADE’s 2025 Member Meeting held in Minneapolis, Minnesota.
BioMADE, a manufacturing innovation institute of the Department of Defense, plans to purchase facilities in Maple Grove, Minnesota and Hayward, California, for the projects. Both facilities will be part of BioMADE’s national network of bioindustrial manufacturing infrastructure.
BioMADE’s Minnesota Facility
BioMADE finalized a $132 million investment to establish a demonstration-scale biomanufacturing facility in Maple Grove. The 122,000 square foot facility will prioritize chemicals and materials, including the processing of volatile liquids. It will have demonstration-scale piloting equipment, including two 25,000-liter fermenters, as well as downstream processing equipment like centrifuge, membrane filtration skid, ion exchange columns, crystallizer and drying equipment. The Maple Grove facility will also support demonstration-scale manufacturing capabilities for analytical testing and process development.
BioMADE’s California Facility
A day after the planned Minnesota facility was announced, OSD ManTech Director Keith DeVries revealed that BioMADE is also set to acquire a 25,000 square foot facility in Hayward, California, as part of efforts to accelerate advancements in biotechnology and biomanufacturing.
BioMADE finalized an agreement with Lygos to transform its pilot biomanufacturing infrastructure into a national multi-user facility. BioMADE intends to add fermentation capacity and downstream processing capabilities to the facility’s existing processing equipment. The Hayward facility, which will be opened in 2026, will feature spaces for piloting, processing and analytical work.
